Wang, Q.; Librizzi, D.; Bagheri, S.; Ebrahimifard, A.; Hojjat Shamami, A.; Rinke, A.; Eilsberger, F.; Luster, M.; Hooshyar Yousefi, B.
Theranostic Radiopharmaceuticals of Somatostatin Receptors for Patients with Neuroendocrine Tumors: Agonists Versus Antagonists—A Systematic Review and Meta-Analysis. Int. J. Mol. Sci. 2025, 26, 8539.
https://doi.org/10.3390/ijms26178539
AMA Style
Wang Q, Librizzi D, Bagheri S, Ebrahimifard A, Hojjat Shamami A, Rinke A, Eilsberger F, Luster M, Hooshyar Yousefi B.
Theranostic Radiopharmaceuticals of Somatostatin Receptors for Patients with Neuroendocrine Tumors: Agonists Versus Antagonists—A Systematic Review and Meta-Analysis. International Journal of Molecular Sciences. 2025; 26(17):8539.
https://doi.org/10.3390/ijms26178539
Chicago/Turabian Style
Wang, Qi, Damiano Librizzi, Shamim Bagheri, Ali Ebrahimifard, Azimeh Hojjat Shamami, Anja Rinke, Friederike Eilsberger, Markus Luster, and Behrooz Hooshyar Yousefi.
2025. "Theranostic Radiopharmaceuticals of Somatostatin Receptors for Patients with Neuroendocrine Tumors: Agonists Versus Antagonists—A Systematic Review and Meta-Analysis" International Journal of Molecular Sciences 26, no. 17: 8539.
https://doi.org/10.3390/ijms26178539
APA Style
Wang, Q., Librizzi, D., Bagheri, S., Ebrahimifard, A., Hojjat Shamami, A., Rinke, A., Eilsberger, F., Luster, M., & Hooshyar Yousefi, B.
(2025). Theranostic Radiopharmaceuticals of Somatostatin Receptors for Patients with Neuroendocrine Tumors: Agonists Versus Antagonists—A Systematic Review and Meta-Analysis. International Journal of Molecular Sciences, 26(17), 8539.
https://doi.org/10.3390/ijms26178539
